SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

4.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

5.

Pressing the Sleep button could have a positive impact on cognition.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot